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Lifestyle interventions are feasible and acceptable and may help to reduce 
premature mortality in schizophrenia: A response to Galletly  
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Galletly’s commentary1 on new data describing years of potential life lost for people with 
schizophrenia broadens discussion beyond excessive rates of obesity and premature 
metabolic syndrome, highlights social concomitants of living with a severe mental illness, 
and outlines how poverty and social disadvantage contribute to poor medical care in these 
patients.  We agree that addressing socioeconomic disparities, improving access to medical 
care and changing prescribing practices are priorities in improving physical health outcomes 
in people with schizophrenia. 
 
There is no ‘silver bullet’ to reducing these physical health disparities and a multi-faceted, 
committed response is needed. However, we dispute the statement that lifestyle 
interventions show little evidence of reducing cardiovascular risk, especially since such 
interventions are broadly as effective as pharmacological interventions2. The evidence 
shows that appropriately-designed behavioural interventions that provide sufficient support 
to patients to increase their autonomy significantly reduce cardiometabolic risk factors in 
the short to medium term,3. If maintained over the long-term, we can expect physical health 
outcomes and life expectancy to improve, as is well-documented in the general population4.  
 
Galletly1 asserts that “It is time to look beyond trying to coerce patients with schizophrenia 
to improve their lifestyles”. We contend that patients are interested in achieving lifestyle 
change5, and targeted interventions have a major role to play in a wholistic approach to 
addressing the major health inequalities in this vulnerable population. Indeed, ingrained 
inequality is one key reason why lifestyle interventions are an essential part of integrated 
‘best practice’ care. Adequate sleep, regular exercise and a healthy diet should be key 
contributors to well-being a healthy life for everyone in society, but these are sadly absent 
for most people living with schizophrenia.  
There is a critical need for more research to address the challenges of implementing 
behaviour change in a cost-effective fashion as part of routine care. Behavioural 
interventions beginning at the same time as antipsychotic treatment is one promising 
approach that requires further research, to determine whether ‘early intervention’ for 
physical health in people with schizophrenia is a feasible and effective method for reducing 
risk.  
We believe it is important that therapeutic nihilism does not limit access to the benefits of 
lifestyle interventions for people living with schizophrenia. Rather, the growing evidence-
base will enable clearer understanding as to how and when to implement lifestyle 
interventions as part of multi-faceted strategies to reduce premature death in people with 
schizophrenia.  
 
References 
1 Galletly CA. Premature death in schizophrenia: bridging the gap. Lancet Psychiatry. 
2017. Published Online February 21, 2017 http://dx.doi.org/10.1016/ S2215-
0366(17)30079-2. 
 
2 Taylor J, Stubbs B, Hewitt C, et al. The effectiveness of pharmacological and non-
pharmacological interventions for improving glycaemic control in adults with severe mental 
illness: A systematic review and meta-analysis. PLoS One. 2017 Jan 5; 12(1):e0168549. 
 
3 McGinty EE, Baller J, Azrin ST, Juliano-Bult D, Daumit GL. Interventions to address 
medical conditions and health-risk behaviors among persons with serious mental illness: A 
comprehensive review. Schiz Bull 2016; 42: 96-124. 
 
4 Paffenbarger Jr RS, Hyde RT, Wing AL, et al. The association of changes in physical-
activity level and other lifestyle characteristics with mortality among men. New England 
Journal of Medicine. 1993;328(8):538-545. 
 
5  Archie SM, Goldberg JO, Akhtar-Danesh N, et al. Psychotic disorders, eating habits, 
and physical activity: who is ready for lifestyle changes? Psychiatric Services. 
2007;58(2):233-239 
 
 
